Niams:supply:protein prep platform: n/a
Active Purchase Order Awarded Last action
- Contract number
- 75N98026P01265
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $496,081
Award facts
- Opportunity
-
- Existing Illumina sequencing Infrastructure Pre-Solicitation · PCANIAMS08113 · Posted Jul 20, 2026
- Contract value 100% obligated
- $496,081.25 Current and potential, with all options
- Completion date 36% complete
- Current and potential, with all options
- Funding agency
- National Insititue of Arthritis and Musculoskeletal and Skin Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Lanham, MD 20706, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm-fixed-price purchase order to Illumina, Inc. valued at $496,081.25 on August 13, 2026, for the Illumina Protein Prep platform, a next-generation sequencing-based proteomics system. No set-aside was used. Performance occurs at Lanham, Maryland, with ultimate completion by February 14, 2027. The platform delivers approximately 9,500 SOMAmer protein targets for protein discovery and relative quantification, proprietary dynamic range compression technology for detecting low-abundance proteins, and native integration with Illumina sequencing workflows and DRAGEN bioinformatics pipelines. NIAMS determined that no other commercially available proteomics platform provides the same combination of protein target coverage, NGS-based scalability, SOMAmer chemistry, dynamic range compression, and seamless integration with existing Illumina systems, including the NovaSeq X Plus platform already in place. The procurement was sole-sourced, with capability statements solicited through July 30, 2026.
Quick answers
Who was awarded contract 75N98026P01265?
75N98026P01265 was awarded to Illumina, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on August 13, 2026.
How much is contract 75N98026P01265 worth?
The government has obligated $496,081 on 75N98026P01265.
Which agency awarded contract 75N98026P01265?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026P01265, with funding from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health).
Was contract 75N98026P01265 competed?
The extent of competition for 75N98026P01265 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award